✦ LIBER ✦

Chronomodulated administration of oxaliplatin plus capecitabine (XELOX) as first line chemotherapy in advanced colorectal cancer patients: phase II study

✍ Scribed by Daniele Santini; Bruno Vincenzi; Gaia Schiavon; Marisa Di Seri; Vladimir Virzí; Bruno Spalletta; Marco Caricato; Roberto Coppola; Giuseppe Tonini

Publisher: Springer
Year: 2006
Tongue: English
Weight: 328 KB
Volume: 59
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-006-0302-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of capecitabine plus oxal

Phase II study of capecitabine plus oxaliplatin (XELOX) as first-line treatment and followed by maintenance of capecitabine in patients with metastatic colorectal cancer

✍ Yu Hong Li; Hui Yan Luo; Feng Hua Wang; Zhi Qiang Wang; Miao Zhen Qiu; Yan Xia S 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 234 KB

Phase II study of short-course capecitab

Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study

✍ T. Waddell; S. Gollins; W. Soe; J. Valle; J. Allen; D. Bentley; J. Morris; A. Ll 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 448 KB

Phase 2 trial of oxaliplatin plus capeci

Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer

✍ Henry Q. Xiong; Gauri R. Varadhachary; Joan C. Blais; Kenneth R. Hess; James L. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB 👁 2 views

Mitomycin-C and capecitabine as third-li

Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study

✍ Do Hyoung Lim; Young Suk Park; Byeong-Bae Park; Sang Hoon Ji; Jeeyun Lee; Keon W 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 200 KB

Phase II study of irinotecan as first-li

Phase II study of irinotecan as first-line chemotherapy for patients with advanced colorectal carcinoma

✍ José Luis Fírvida; Antonio Irigoyen; Sergio Vázquez-Estévez; Pilar Díz; Manuel C 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

Phase I/II study of a combination of doc

Phase I/II study of a combination of docetaxel, capecitabine, and cisplatin (DXP) as first-line chemotherapy in patients with advanced gastric cancer

✍ Yoon-Koo Kang; Min-Hee Ryu; Changhoon Yoo; Heung-Moon Chang; Jeong Hwan Yook; Su 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 334 KB